High Clinical Concordance of Drug Resistance in Patient-derived Orthotopic Xenograft (PDOX) Mouse Models: First Step to Validated Precise Individualized Cancer Chemotherapy
Anticancer Research · 2023
DOI: 10.21873/anticanres.16622 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Anticancer Research, 2023. Verfasst von Takashi Higuchi und 6 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer, Inc., San Diego, CA, U.S.A.; guchi@384.jp. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- AntiCancer, Inc., San Diego, CA, U.S.A.; guchi@384.jp.
- Department of Surgery, University of California, San Diego, CA, U.S.A.
- Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
- AntiCancer, Inc., San Diego, CA, U.S.A.; all@anticancer.com.
Zitieren
APA
Higuchi, T., Yamamoto, N., Hayashi, K., Miwa, S., Igarashi, K., Tsuchiya, H., & Hoffman, R. M. (2023). High Clinical Concordance of Drug Resistance in Patient-derived Orthotopic Xenograft (PDOX) Mouse Models: First Step to Validated Precise Individualized Cancer Chemotherapy. Anticancer Research. https://doi.org/10.21873/anticanres.16622
Vancouver
Higuchi T, Yamamoto N, Hayashi K, Miwa S, Igarashi K, Tsuchiya H, et al. High Clinical Concordance of Drug Resistance in Patient-derived Orthotopic Xenograft (PDOX) Mouse Models: First Step to Validated Precise Individualized Cancer Chemotherapy. Anticancer Research. 2023. doi:10.21873/anticanres.16622
BibTeX
@article{Higuchi2023,
author = {Higuchi, Takashi and Yamamoto, Norio and Hayashi, Katsuhiro and Miwa, Shinji and Igarashi, Kentaro and Tsuchiya, Hiroyuki and Hoffman, Robert M},
title = {High Clinical Concordance of Drug Resistance in Patient-derived Orthotopic Xenograft (PDOX) Mouse Models: First Step to Validated Precise Individualized Cancer Chemotherapy},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16622}
}
EUVIMED